These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33417506)

  • 41. Asking the right questions to get the right answers: using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients.
    Holch P; Warrington L; Potrata B; Ziegler L; Hector C; Keding A; Harley C; Absolom K; Morris C; Bamforth L; Velikova G
    Acta Oncol; 2016; 55(9-10):1220-1226. PubMed ID: 27551774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Smartphone-Enhanced Symptom Management In Psychosis: Open, Randomized Controlled Trial.
    Lewis S; Ainsworth J; Sanders C; Stockton-Powdrell C; Machin M; Whelan P; Hopkins R; He Z; Applegate E; Drake R; Bamford C; Roberts C; Wykes T
    J Med Internet Res; 2020 Aug; 22(8):e17019. PubMed ID: 32788150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial.
    Klafke N; Mahler C; von Hagens C; Uhlmann L; Bentner M; Schneeweiss A; Mueller A; Szecsenyi J; Joos S
    Cancer Med; 2019 Jul; 8(8):3666-3676. PubMed ID: 31115192
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Essential Components of an Electronic Patient-Reported Symptom Monitoring and Management System: A Randomized Clinical Trial.
    Mooney K; Gullatte M; Iacob E; Alekhina N; Nicholson B; Sloss EA; Lloyd J; Moraitis AM; Donaldson G
    JAMA Netw Open; 2024 Sep; 7(9):e2433153. PubMed ID: 39269704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial.
    Ettl J; Quek RGW; Lee KH; Rugo HS; Hurvitz S; Gonçalves A; Fehrenbacher L; Yerushalmi R; Mina LA; Martin M; Roché H; Im YH; Markova D; Bhattacharyya H; Hannah AL; Eiermann W; Blum JL; Litton JK
    Ann Oncol; 2018 Sep; 29(9):1939-1947. PubMed ID: 30124753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive behavioral therapy or graded exercise therapy compared with usual care for severe fatigue in patients with advanced cancer during treatment: a randomized controlled trial.
    Poort H; Peters MEWJ; van der Graaf WTA; Nieuwkerk PT; van de Wouw AJ; Nijhuis-van der Sanden MWG; Bleijenberg G; Verhagen CAHHVM; Knoop H
    Ann Oncol; 2020 Jan; 31(1):115-122. PubMed ID: 31912784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.
    Coens C; Suciu S; Chiarion-Sileni V; Grob JJ; Dummer R; Wolchok JD; Schmidt H; Hamid O; Robert C; Ascierto PA; Richards JM; Lebbé C; Ferraresi V; Smylie M; Weber JS; Maio M; Bottomley A; Kotapati S; de Pril V; Testori A; Eggermont AMM
    Lancet Oncol; 2017 Mar; 18(3):393-403. PubMed ID: 28162999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of a web-based cognitive-behavioral tool to improve mental well-being in the general population: randomized controlled trial.
    Powell J; Hamborg T; Stallard N; Burls A; McSorley J; Bennett K; Griffiths KM; Christensen H
    J Med Internet Res; 2012 Dec; 15(1):e2. PubMed ID: 23302475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.
    Vogel A; Qin S; Kudo M; Su Y; Hudgens S; Yamashita T; Yoon JH; Fartoux L; Simon K; López C; Sung M; Mody K; Ohtsuka T; Tamai T; Bennett L; Meier G; Breder V
    Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):649-658. PubMed ID: 34087115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study.
    Raimondi A; Di Maio M; Morano F; Corallo S; Lonardi S; Antoniotti C; Rimassa L; Sartore-Bianchi A; Tampellini M; Ritorto G; Murialdo R; Clavarezza M; Zaniboni A; Adamo V; Tomasello G; Petrelli F; Antonuzzo L; Giordano M; Cinieri S; Longarini R; Bergamo F; Niger M; Antista M; Peverelli G; de Braud F; Di Bartolomeo M; Pietrantonio F
    Eur J Cancer; 2020 Aug; 135():230-239. PubMed ID: 32623288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparing effects in regular practice of e-communication and Web-based self-management support among breast cancer patients: preliminary results from a randomized controlled trial.
    Børøsund E; Cvancarova M; Moore SM; Ekstedt M; Ruland CM
    J Med Internet Res; 2014 Dec; 16(12):e295. PubMed ID: 25525672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial.
    Harbeck N; Iyer S; Turner N; Cristofanilli M; Ro J; André F; Loi S; Verma S; Iwata H; Bhattacharyya H; Puyana Theall K; Bartlett CH; Loibl S
    Ann Oncol; 2016 Jun; 27(6):1047-1054. PubMed ID: 27029704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial.
    Cella D; Grünwald V; Escudier B; Hammers HJ; George S; Nathan P; Grimm MO; Rini BI; Doan J; Ivanescu C; Paty J; Mekan S; Motzer RJ
    Lancet Oncol; 2019 Feb; 20(2):297-310. PubMed ID: 30658932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using Machine Learning to Predict Unplanned Hospital Utilization and Chemotherapy Management From Patient-Reported Outcome Measures.
    Wójcik Z; Dimitrova V; Warrington L; Velikova G; Absolom K
    JCO Clin Cancer Inform; 2024 Apr; 8():e2300264. PubMed ID: 38669610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin.
    Moaven O; Votanopoulos KI; Shen P; Mansfield P; Bartlett DL; Russell G; McQuellon R; Stewart JH; Levine EA
    Ann Surg Oncol; 2020 Mar; 27(3):772-780. PubMed ID: 31720933
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural distress screening and supportive care for patients with lung cancer on systemic therapy: A randomised controlled trial.
    Geerse OP; Hoekstra-Weebers JE; Stokroos MH; Burgerhof JG; Groen HJ; Kerstjens HA; Hiltermann TJ
    Eur J Cancer; 2017 Feb; 72():37-45. PubMed ID: 28024265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial.
    Dos Santos M; Hardy-Léger I; Rigal O; Licaj I; Dauchy S; Levy C; Noal S; Segura C; Delcambre C; Allouache D; Parzy A; Barriere J; Petit T; Lange M; Capel A; Clarisse B; Grellard JM; Lefel J; Joly F
    Cancer; 2020 Dec; 126(24):5328-5336. PubMed ID: 32996583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emotion And Symptom-focused Engagement (EASE): a randomized phase II trial of an integrated psychological and palliative care intervention for patients with acute leukemia.
    Rodin G; Malfitano C; Rydall A; Schimmer A; Marmar CM; Mah K; Lo C; Nissim R; Zimmermann C
    Support Care Cancer; 2020 Jan; 28(1):163-176. PubMed ID: 31001692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized Trial of a Smartphone Mobile App to Improve Symptoms and Adherence to Oral Therapy for Cancer.
    Greer JA; Jacobs JM; Pensak N; Nisotel LE; Fishbein JN; MacDonald JJ; Ream ME; Walsh EA; Buzaglo J; Muzikansky A; Lennes IT; Safren SA; Pirl WF; Temel JS
    J Natl Compr Canc Netw; 2020 Feb; 18(2):133-141. PubMed ID: 32023526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.